Pulmonx Corporation provided earnings guidance for the full year 2024. For the period, the company expects revenue for the full year 2023 to be in the range of $81 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.41 USD | -3.89% | -14.36% | -34.04% |
01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
01/05 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.04% | 326M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
-0.74% | 1.99B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024